Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
March 5, 2026
Eiger BioPharmaceuticals to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference
July 7, 2021
Related Post
-
-
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab
March 5, 2026
-
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
March 4, 2026
-
Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program
March 4, 2026